Royalty Pharma所有資訊

Royalty Pharma | 4：持股變動聲明-高管 Hite Christopher

05/16 17:47 (美東)

Royalty Pharma | 10-Q：季度報表

05/09 09:10 (美東)

Royalty Pharma | 8-K：特許權制藥公佈2024年第一季度業績

05/09 07:22 (美東)

Royalty Pharma | DEF 14A：股東委託書決議

04/25 22:17 (美東)

Royalty Pharma | ARS：年度報告

04/25 16:14 (美東)

Royalty Pharma | DEFA14A：其他

04/25 16:12 (美東)

Royalty Pharma | 144：擬議出售證券

04/03 16:53 (美東)

Royalty Pharma | 144：擬議出售證券

04/03 16:53 (美東)

Royalty Pharma | 4：持股變動聲明-董事 Fernandez Henry A

04/02 17:36 (美東)

Royalty Pharma | 4：持股變動聲明-董事 Bassler Bonnie L

04/02 17:32 (美東)

Royalty Pharma | 144：擬議出售證券

02/28 22:46 (美東)

Royalty Pharma | 4：持股變動聲明-董事 RIGGS RORY B

02/22 19:28 (美東)

Royalty Pharma | 10-K：年度報表

02/15 09:12 (美東)

Royalty Pharma | 8-K：重大事件

02/15 07:37 (美東)

Royalty Pharma | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(8.54%)

02/13 22:37 (美東)

Royalty Pharma | SC 13G/A：超過5%持股股東披露文件(修正)-General Atlantic, L.P.(5.6%),GAP Coinvestments CDA, L.P.(5.6%)等

02/13 10:20 (美東)

Royalty Pharma | SC 13G/A：超過5%持股股東披露文件(修正)-Morgan Stanley(9.2%),Morgan Stanley Investment Management Inc.(8.9%)

02/09 15:15 (美東)

Royalty Pharma | SC 13G/A：超過5%持股股東披露文件(修正)-FMR LLC(7.099%),Abigail P. Johnson(7.099%)

02/09 09:55 (美東)

Royalty Pharma | 8-K：重大事件

02/06 07:06 (美東)

Royalty Pharma | UPLOAD：其他

01/30 14:35 (美東)